Circulating Fibroblast Growth Factor 21 is Associated with Diastolic Dysfunction in Heart Failure Patients with Preserved Ejection Fraction

Fibroblast growth factor 21 (FGF21), a polypeptide ligand promoted glucose homeostasis and lipids metabolism, was recently reported to attenuate cardiac hypertrophy. The aim of this study was to investigate the impact of FGF21 in diastolic heart failure. Subjects admitted for coronary angiogram were...

Descripción completa

Detalles Bibliográficos
Autores principales: Chou, Ruey-Hsing, Huang, Po-Hsun, Hsu, Chien-Yi, Chang, Chun-Chin, Leu, Hsin-Bang, Huang, Chin-Chou, Chen, Jaw-Wen, Lin, Shing-Jong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030655/
https://www.ncbi.nlm.nih.gov/pubmed/27650781
http://dx.doi.org/10.1038/srep33953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030655/
https://www.ncbi.nlm.nih.gov/pubmed/27650781
http://dx.doi.org/10.1038/srep33953

Ejemplares similares